Sales & Marketing

Pharmaceutical companies are increasingly using radio advertising, both traditional and digital.

Survey: HCPs Rank Corporate Reputation as Leading Factor After Drug Efficacy and Safety

Enterprise generative AI focused on life sciences to bring life-saving drugs to market faster.

The drug is Xspray Pharma's first innovative cancer therapy and is set to launch later in 2023.

Blueprint Medicines Corporation will regain global commercialization and development rights to Gavreto (pralsetinib).

The therapy to treat a type of inherited bleeding disorder known as hemophilia A is expected to launch in the United States in April.

Wall Street Journal reports psychedelic-therapy industry gets a reality trip as investors focus on treatments costing less time and money

Bausch + Lomb has launched a social media campaign called "What Sight Inspires You" to raise awareness of age-related macular degeneration.

Sermo and LiveWorld survey of 50+ pharma marketers and 200+ physicians finds that social media plays a major role in influencing perceptions of medications, prescribing Habits, ongoing medical education and professional networking.

The capabilities will support life sciences organizations with a variety of use cases, including health care provider (HCP) interactions, HCP education, and patient education.

A new study shows that a growing number of younger generations are turning to social media platforms such as TikTok and Instagram influencers for health advice.

Move enables FINN to address pressing health priorities in developed and developing nations and expands Hyderus global service capabilities and client offerings and Hyderus co-founders Mark Chataway and Christopher Nial join FINN global health leaders team.

Webinar Date/Time: Mon, Mar 13, 2023 11:00 AM EDT

Fran Pollaro talks with Faruk Capan is the CEO, EVERSANA INTOUCH & Chief Innovation Officer, EVERSANA about the arrival of Chat GPT and generative AI in the public consciousness. This is just the beginning.

Takeda's partnership with Novavax to manufacture 150 million doses of COVID-19 vaccine has been heavily impacted.

AstraZeneca is forecasting growth in 2023 and beyond, relying on its expanding line of cancer, metabolic, and rare disease drugs to offset declining COVID product sales.

Branding agency experts share what to know when it comes to legal, regulatory, and creative approaches in the complex drug-naming process, with its potential to shape a campaign’s success.

BMS launched a new direct-to-consumer (DTC) campaign for SOTYKTU™ (deucravacitinib) for the plaque psoriasis community.

U.S. Food and Drug Administration has greenlighted the use of Trodelvy for a third indication.

Sysnav Healthcare and Roche enter a partnership to facilitate development of industry standard outcome measurements in diseases associated with movement impairments, as well as designing the next generation of wearable technology based on Sysnav's technology.

What’s changing in post-pandemic HCP access? Veeva’s vice president of global business consulting unveils the latest data.

Q&A addresses patient care and leads to digital solutions like telehealth as a strong delivery vehicle and an opportunity for marketers.

"AH-ha!™ It's Acne Hormones" features people affected by acne and highlights "AH-ha" moments to "pop" common acne myths and misconceptions.

Launch Ready from Day One is designed to empower a company's customer facing teams to drive demand, simplify access, and create a seamless and more integrated customer experience.

New structure strengthens offerings and drives the addition of diversified marketing services.